AP - Federal regulators have ruled that a potential breast cancer treatment from ImmunoGen failed to meet the standard for accelerated approval, the company said Friday.
AP - Chindex International sold $14 million of its shares to another Chinese medical concern as part of its plans to form a new joint venture, the company said Friday.
AP - Gov. Brian Schweitzer, cooking up a new plan to get cheaper prescription drugs for state residents, said he wants to let every Montanan get discounted medicine through Medicaid.
The Swiss pharmaceutical group Novartis plans to build Latin America's first vaccine factory in Brazil with an investment of 300 to 500 million dollars, the financial daily Valor reported Thursday.
AP - Swiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion.
AP - Somaxon Pharmaceuticals Inc. will team with Procter & Gamble Co. to co-promote the insomnia treatment Silenor to thousands of doctors and pharmacies.
AP - Swiss pharmaceutical company Roche Group says it has teamed up with Massachusetts-based Aileron Therapeutics to develop a new class of drugs in a deal potentially worth over $1.1 billion.
Reuters - A law intended to speed up development of new drugs for U.S. kids has ended up financing clinical trials in poor countries, where the medicines might never become available.
AP - Shares of Jazz Pharmaceuticals Inc. jumped Wednesday after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.
SUGAR LAND, TX--(Marketwire - September 3, 2010) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The million dollar question continues to be is the economy better, is it getting worse, or is it somewhere in between? Theories abound, talking heads offer wildly varied opinions, while in regard to active capital investment, the facts can only be found in hard
